Simon Chasles was staring at a screen in a Montreal lab when the first 3D models of microRNA and messenger RNA interactions snapped into focus—structures never before mapped with such precision. At the Université de Montréal’s Institute for Research in Immunology and Cancer (IRIC), Chasles, a Ph.D. student in computer science, had just helped crack open a new dimension in RNA biology. Working under Professor François Major, director of IRIC’s RNA engineering research unit, he developed RIMap-RISC, a groundbreaking database that models how microRNAs bind to messenger RNAs using full 3D molecular structures—not just genetic sequences. Published in Genome Biology in 2026, this tool marks a turning point in how scientists understand gene regulation.
For decades, researchers have known that microRNAs—tiny RNA molecules—play a critical role in silencing genes by latching onto messenger RNAs, the molecular messengers that carry DNA’s instructions for building proteins. But until now, most models relied solely on sequence matching, overlooking the physical shape and structural dynamics that determine whether and how tightly these molecules bind. RIMap-RISC changes that by integrating structural biology into the analysis, offering a far more accurate picture of how gene silencing occurs in both healthy cells and diseases like cancer.
“This is the first time such modeling has been done systematically,” said Major, whose lab bridges computational science and molecular biology. The database covers the entire human transcriptome, mapping thousands of microRNA–mRNA interactions with structural detail. It’s freely accessible online and equipped with a programmable interface, allowing researchers worldwide to plug it into their bioinformatics workflows. The team expects it will accelerate discoveries in RNA-based therapeutics, improve target prediction for drug development, and deepen understanding of genetic regulation in complex diseases.
What makes RIMap-RISC especially powerful is its foundation in real structural data. Instead of predicting interactions based on base-pairing rules alone, it uses experimentally informed 3D models to simulate how microRNAs physically engage their targets. This structural lens reveals why some microRNAs bind more effectively than others, even with imperfect sequence matches—a phenomenon that has long puzzled scientists. By making this data reusable and computationally accessible, the platform invites collaboration and innovation across labs and disciplines.
As RNA biology moves beyond sequencing and into spatial dynamics, tools like RIMap-RISC are setting a new standard. For researchers studying everything from tumor suppression to viral infection, the ability to model RNA interactions in three dimensions opens fresh pathways to intervention. In Montreal, where computer science meets cancer research, a new chapter in molecular exploration has quietly begun—one base pair, and one breakthrough, at a time.